Avanir Pharmaceuticals Inc (AVNR.OQ)
AVNR.OQ on NASDAQ Stock Exchange Global Select Market
4.76USD
10:56am EDT
4.76USD
10:56am EDT
Price Change (% chg)
$0.05 (+1.06%)
$0.05 (+1.06%)
Prev Close
$4.71
$4.71
Open
$4.74
$4.74
Day's High
$4.83
$4.83
Day's Low
$4.72
$4.72
Volume
64,289
64,289
Avg. Vol
447,160
447,160
52-wk High
$5.09
$5.09
52-wk Low
$2.07
$2.07
About
AVANIR Pharmaceuticals, Inc. (AVANIR) is a pharmaceutical company focused on developing and commercializing therapeutic products for the treatment of central nervous system disorders. The Company focuses on products for the central nervous system. It also has a number of partnered programs in other therapeutic areas. Its... (more)
Overall
| Beta: | 1.84 |
| Market Cap (Mil.): | $682.74 |
| Shares Outstanding (Mil.): | 145.11 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| AVNR.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 47.13 | 37.76 |
| EPS (TTM): | -0.40 | -- | -- |
| ROI: | -94.51 | -2.58 | 18.76 |
| ROE: | -121.06 | -2.66 | 19.59 |
Competitors
| Price | Change | |
|---|---|---|
| Novartis AG (NOVN.VX) | CHF66.60 | +0.35 |
| Pfizer Inc. (PFE.N) | $29.19 | -0.04 |
| Johnson & Johnson (JNJ.N) | $93.84 | +0.34 |
| Merck & Co., Inc. (MRK.N) | $48.10 | -0.07 |
| Bayer AG (BAYGn.DE) | €89.10 | +1.75 |
| Bayer AG (BAYE.F) | -- | -- |
Earnings vs.
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: S&P Capital IQ Quantitative Report
|
$69.00
|
|
Provider: Pechala's Reports
|
$15.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: Jefferson Research
|
$20.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

